| Economic impact of medication non-adherence by disease groups: a systematic review RL Cutler, F Fernandez-Llimos, M Frommer, C Benrimoj, ... BMJ open 8 (1), e016982, 2018 | 827 | 2018 |
| Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system RL Cutler, A Torres-Robles, E Wiecek, B Drake, N Van der Linden, ... Patient preference and adherence, 853-862, 2019 | 59 | 2019 |
| Impact of a multicomponent digital therapeutic mobile app on medication adherence in patients with chronic conditions: retrospective analysis E Wiecek, A Torres-Robles, RL Cutler, SI Benrimoj, V Garcia-Cardenas Journal of medical Internet research 22 (8), e17834, 2020 | 47 | 2020 |
| Using dispensing data to evaluate adherence implementation rates in community pharmacy A Torres-Robles, E Wiecek, R Cutler, B Drake, SI Benrimoj, ... Frontiers in pharmacology 10, 130, 2019 | 41 | 2019 |
| Economic impact of medication nonadherence by disease groups: a systematic review. BMJ Open 8 (1): e016982 RL Cutler, F Fernandez-Llimos, M Frommer, C Benrimoj, ... | 34 | 2018 |
| Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018; 8 (1): e016982 RL Cutler, F Fernandez-Llimos, M Frommer, C Benrimoj, ... Epub 2018/01/24. https://doi. org/10.1136/bmjopen-2017-016982 PMID: 29358417, 0 | 23 | |
| Using dispensing data to evaluate adherence implementation rates in community pharmacy. Front Pharmacol. 2019; 10-(February): 1–9 A Torres-Robles, E Wiecek, R Cutler | 16 | |
| Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018 Jan 21; 8 (1): e016982. 10.1136/bmjopen-2017-016982 RL Cutler, F Fernandez-Llimos, M Frommer, C Benrimoj, ... | 13 | |
| Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018 Jan 21; 8 (1): e016982. doi: 10.1136/bmjopen-2017-016982 RL Cutler, F Fernandez-Llimos, M Frommer, C Benrimoj, ... | 11 | |
| An evidence-based model to consolidate medication adherence cost estimation: the medication adherence cost estimation framework RL Cutler, NV der Linden, SI Benrimoj, F Fernandez-Llimos, ... Journal of comparative effectiveness research 8 (8), 555-567, 2019 | 4 | 2019 |
| Exploring the influence of the microbiome on the pharmacology of anti-asthmatic drugs M Chan, C Ghadieh, I Irfan, E Khair, N Padilla, S Rebeiro, A Sidgreaves, ... Naunyn-schmiedeberg's Archives of Pharmacology 397 (2), 751-762, 2024 | | 2024 |
| Effect of mobile applications on the spontaneous reporting of adverse drug reactions: A systematic review and meta-analysis YK Avong, R Cutler, GA Kayode, V Adekanmbi, OA Uthman, K Rogers, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 657-658, 2022 | | 2022 |
| Oral Presentation: Nigeria is Making Progress Implementing the Active Drug Safety Monitoring and Management Scheme for New and Repurposed Antituberculosis Drugs YK Avong, AS Abiodun, B Jatau, AT Shuibu, C Elagbaje, A Opadeyi, I Ali, ... Drug Safety 44 (12), 1395-1395, 2021 | | 2021 |
| The clinical and economic impact of a multicomponent digital therapeutic mobile app: a retrospective analysis A Torres-Robles, R Cutler, V Garcia-Cardenas | | 2021 |
| Current practice in cancer pharmacotherapy LG Pont, K Dua, RL Cutler, H Benson, M Hagi, VG Cardenas, CCH Smit, ... Advanced Drug Delivery Systems in the Management of Cancer, 9-15, 2021 | | 2021 |
